Showing results (1-10 of 11,753) with videos related to
Sort By:
Pageof 1,176
Pharmaceutical Statistics|August 8, 2023
Calculation of Phase 2 dose-finding study sample size for reliable Phase 3 dose selectionFang Liu, Qing Zhao, Anthony J Rodgers, et al.Pharmaceutical Statistics|June 21, 2017
Missing data in clinical trials: control-based mean imputation and sensitivity analysisDevan V Mehrotra, Fang Liu, Thomas PermuttPharmaceutical Statistics|April 5, 2017
Enabling robust assessment of QTc prolongation in early phase clinical trialsDevan V Mehrotra, Li Fan, Fang Liu, et al.Pharmaceutical Statistics|September 18, 2014
A recommended analysis for 2 × 2 crossover trials with baseline measurementsDevan V MehrotraClinical Trials (London, England)|April 13, 2019
A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysisDevan V MehrotraStatistics in Medicine|June 15, 2018
Hazard ratio estimation and inference in clinical trials with many tied event timesDevan V Mehrotra, Yiwei ZhangBiometrical Journal. Biometrische Zeitschrift|September 16, 2006
Adaptive vs. group sequential self-designing trialsDevan V Mehrotra, Xiaoyin FanStatistics in Medicine|September 2, 2008
An efficient method for accommodating potentially underpowered primary endpointsJianjun Li, Devan V MehrotraControlled Clinical Trials|April 12, 2003
Stratified experiments reexamined with emphasis on multicenter trialsJitendra Ganju, Devan V MehrotraStatistics in Medicine|April 21, 2006
Analysis of antiretroviral immunotherapy trials with potentially non-normal and incomplete longitudinal dataRobin Mogg, Devan V MehrotraPageof 1,176